The Pharmacokinetic and Pharmacodynamic Properties of Hydroxychloroquine and Dose Selection for COVID-19: Putting the Cart Before the Horse
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Pharmacokinetic and Pharmacodynamic Properties of Hydroxychloroquine and Dose Selection for COVID-19: Putting the Cart Before the Horse
Authors
Keywords
-
Journal
Infectious Diseases and Therapy
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-08-01
DOI
10.1007/s40121-020-00325-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
- (2020) Manli Wang et al. CELL RESEARCH
- Ranking Self-reported Gastrointestinal Side Effects of Pharmacotherapy in Sarcoidosis
- (2020) M. Drent et al. LUNG
- Clinical Characteristics of Coronavirus Disease 2019 in China
- (2020) Wei-jie Guan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Towards Optimization of Hydroxychloroquine Dosing in Intensive Care Unit COVID-19 Patients
- (2020) Sophie Perinel et al. CLINICAL INFECTIOUS DISEASES
- In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
- (2020) Xueting Yao et al. CLINICAL INFECTIOUS DISEASES
- Optimizing Hydroxychloroquine Dosing for Patients With COVID‐19: An Integrative Modeling Approach for Effective Drug Repurposing
- (2020) Maria Garcia‐Cremades et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection
- (2020) Jacques Fantini et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality
- (2020) Chi Zhang et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19)
- (2020) James M. Sanders et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19
- (2020) Joshua Geleris et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chloroquine and Hydroxychloroquine in the Era of SARS – CoV2: Caution on Their Cardiac Toxicity
- (2020) Jerry L. Bauman et al. PHARMACOTHERAPY
- Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies
- (2020) Jianjun Gao et al. BioScience Trends
- Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19)
- (2020) Nicholas J. Mercuro et al. JAMA Cardiology
- Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
- (2020) Jia Liu et al. Cell Discovery
- Finding the Dose for Hydroxychloroquine Prophylaxis for COVID‐19: The Desperate Search for Effectiveness
- (2020) Mahmoud Al‐Kofahi et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19
- (2020) Samia Arshad et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
- (2020) David R. Boulware et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
- (2020) Mayla Gabriela Silva Borba et al. JAMA Network Open
- Hydroxychloroquine Blood Levels Predict Hydroxychloroquine Retinopathy
- (2019) Michelle Petri et al. Arthritis & Rheumatology
- Prévalence des effets indésirables de l’hydroxychloroquine (Plaquenil ® ) dans une population dermatologique : étude rétrospective sur 102 patients
- (2018) P. Tétu et al. ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE
- Hydroxychloroquine retinopathy — implications of research advances for rheumatology care
- (2018) April Jorge et al. Nature Reviews Rheumatology
- Increased Incidence of Gastrointestinal Side Effects in Patients Taking Hydroxychloroquine: A Brand-related Issue?
- (2017) AMAR SRINIVASA et al. JOURNAL OF RHEUMATOLOGY
- Chloroquine and Hydroxychloroquine Are Novel Inhibitors of Human Organic Anion Transporting Polypeptide 1A2
- (2016) Chenghao Xu et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Chloroquine analogues in drug discovery: new directions of uses, mechanisms of actions and toxic manifestations from malaria to multifarious diseases
- (2015) M. A. A. Al-Bari JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Hydroxychloroquine Blood Levels in Systemic Lupus Erythematosus: Clarifying Dosing Controversies and Improving Adherence
- (2015) L. Durcan et al. JOURNAL OF RHEUMATOLOGY
- Association of Polymorphisms of Cytochrome P450 2D6 With Blood Hydroxychloroquine Levels in Patients With Systemic Lupus Erythematosus
- (2015) Ji Yeon Lee et al. Arthritis & Rheumatology
- Pharmacokinetics of Hydroxychloroquine and Its Clinical Implications in Chemoprophylaxis against Malaria Caused by Plasmodium vivax
- (2009) H.-S. Lim et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now